APA (7th ed.) Citation

Waidmann, O., Gruber-Rouh, T., Koch, C., Götze, T., Schultheiss, M., Herrmann, E., . . . Finkelmeier, F. (2024). 979P Initial results from the phase II randomized trial comparing TACE with irinotecan and mitomycin C to doxorubicin in intermediate stage HCC (IRITACE trial). Annals of Oncology, 35, S669. https://doi.org/10.1016/j.annonc.2024.08.1039

Chicago Style (17th ed.) Citation

Waidmann, O., et al. "979P Initial Results from the Phase II Randomized Trial Comparing TACE with Irinotecan and Mitomycin C to Doxorubicin in Intermediate Stage HCC (IRITACE Trial)." Annals of Oncology 35 (2024): S669. https://doi.org/10.1016/j.annonc.2024.08.1039.

MLA (9th ed.) Citation

Waidmann, O., et al. "979P Initial Results from the Phase II Randomized Trial Comparing TACE with Irinotecan and Mitomycin C to Doxorubicin in Intermediate Stage HCC (IRITACE Trial)." Annals of Oncology, vol. 35, 2024, p. S669, https://doi.org/10.1016/j.annonc.2024.08.1039.